Breaking News

Quincy Bioscience Receives NSF GMP Recertification

By Kristin Brooks | February 28, 2014

Manufacturing methods in accordance with FDA’s 21 CFR part 111

Quincy Bioscience has received recertification of its GMP facilities registered by NSF International for 2014. The GMP registration verifies that the company has the proper methods, equipment, facilities, and controls in place for producing dietary supplement products in accordance with the FDA’s 21 CFR part 111 regulations on manufacturing, packaging, and distribution.
 
"We're proud to maintain this important recognition for all of our locations," said Mark Underwood, president and co-founder of Quincy Bioscience. "We take good manufacturing practices very seriously in every department of our organization and we're pleased that NSF continues to acknowledge our practice of excellence."
 

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks